Table 4.
Characteristics of the secondary metabolites derived from microorganisms used for cervical cancer treatment.
| Origin | Anti-tumor mechanism | Reference | |
|---|---|---|---|
| Rosoloactone | Trichothecium roseum | Rosoloactone mediates pro-apoptotic effects via the activation of ERS-associated apoptosis and the mitochondria-mediated apoptotic pathway. | (56) |
| PSE | Penicillium sclerotiorum | PSE leads to activation of mitochondrial pathway of apoptosis and exhibites both antioxidant and anti-angiogenic properties. | (57) |
| Streptomyces sp metabolite(s) | Streptomyces sp OA293 | A mTORC1 inhibitor suppresses activation of both of its downstream targets, 4E-BP1 and P70S6k and Akt expression | (58) |
| Polysaccharides | Enterobacter cloacae | Induce the apoptosis of cervical cancer cells through an intrinsic apoptotic pathway | (59) |
| Gliotoxin | Aspergillus sp | Induce apoptosis in Hela and SW1353 cells via the mitochondrial pathway | (60) |